{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:50:50Z","timestamp":1761490250329,"version":"3.37.3"},"reference-count":44,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T00:00:00Z","timestamp":1495584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100005941","name":"Dietmar Hopp Stiftung","doi-asserted-by":"publisher","award":["2009\u2010013856\u201061","ISRCTN 16345835"],"award-info":[{"award-number":["2009\u2010013856\u201061","ISRCTN 16345835"]}],"id":[{"id":"10.13039\/501100005941","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Analysis of the efficiency and toxicity of cyclophosphamide\u2010based stem cell mobilization in patients with relapsed multiple myeloma (<jats:styled-content style=\"fixed-case\">RMM<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Peripheral blood stem cells (<jats:styled-content style=\"fixed-case\">PBSC<\/jats:styled-content>s) were mobilized with high dose cyclophosphamide (2\u00a0g\/m<jats:sup>2<\/jats:sup> daily on days 1 and 2) and G\u2010<jats:styled-content style=\"fixed-case\">CSF<\/jats:styled-content> plus pre\u2010emptive\/rescue plerixafor in <jats:styled-content style=\"fixed-case\">RMM<\/jats:styled-content> patients (first to third relapse) treated within the Re<jats:styled-content style=\"fixed-case\">LA<\/jats:styled-content>psE trial of the German\u2010Speaking Myeloma Multicenter Group (<jats:styled-content style=\"fixed-case\">GMMG<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Mobilization was initiated with high\u2010dose cyclophosphamide (HD\u2010CY) and G\u2010<jats:styled-content style=\"fixed-case\">CSF<\/jats:styled-content> in 30 patients. Fifteen patients received additional pre\u2010emptive\/rescue administration of plerixafor. Stem cell collection was successful (\u22652\u00d710<jats:sup>6<\/jats:sup> <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>34+ cells per kg\u00a0bw) in 77% (23\/30 patients). Patients with prior high\u2010dose melphalan collected a significantly lower median total number of <jats:styled-content style=\"fixed-case\">PBSC<\/jats:styled-content>s than patients without prior high\u2010dose melphalan (3.3\u00d710<jats:sup>6<\/jats:sup> vs 17\u00d710<jats:sup>6<\/jats:sup> <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>34+ cells\/kg\u00a0bw). Toxicity of HD\u2010CY was frequent with 12 serious adverse events (<jats:styled-content style=\"fixed-case\">SAE<\/jats:styled-content>) in 37% of patients (11\/30 patients). Infections accounted for the majority of <jats:styled-content style=\"fixed-case\">SAE<\/jats:styled-content> reports. In two patients, <jats:styled-content style=\"fixed-case\">SAE<\/jats:styled-content>s were lethal (septic shock).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These data proof feasibility of <jats:styled-content style=\"fixed-case\">PBSC<\/jats:styled-content> collection at relapse but emphasize the importance of collection and storage of additional <jats:styled-content style=\"fixed-case\">PBSC<\/jats:styled-content> transplants during first\u2010line treatment when mobilization is more efficient and less toxic.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ejh.12888","type":"journal-article","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T21:49:47Z","timestamp":1491256187000},"page":"42-50","source":"Crossref","is-referenced-by-count":20,"title":["Cyclophosphamide\u2010based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase <scp>III<\/scp> trial Re<scp>LA<\/scp>psE"],"prefix":"10.1111","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4000-6904","authenticated-orcid":false,"given":"Marc\u2010Andrea","family":"Baertsch","sequence":"first","affiliation":[{"name":"Department of Medicine V University Hospital Heidelberg  Heidelberg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Schlenzka","sequence":"additional","affiliation":[{"name":"Department of Medicine V University Hospital Heidelberg  Heidelberg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Lisenko","sequence":"additional","affiliation":[{"name":"Department of Medicine V University Hospital Heidelberg  Heidelberg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Krzykalla","sequence":"additional","affiliation":[{"name":"Biostatistics German Cancer Research Center (DKFZ)  Heidelberg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Becker","sequence":"additional","affiliation":[{"name":"Biostatistics German Cancer Research Center (DKFZ)  Heidelberg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Weisel","sequence":"additional","affiliation":[{"name":"Hematology, Oncology and Immunology University of Tuebingen  Tuebingen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Noppeney","sequence":"additional","affiliation":[{"name":"Hematology University Hospital Essen  Essen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Martin","sequence":"additional","affiliation":[{"name":"Hematology and Oncology Goethe University  Frankfurt Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans W.","family":"Lindemann","sequence":"additional","affiliation":[{"name":"Hematology and Oncology Kath. Krankenhaus Hagen gem. GmbH \u2010 St.\u2010Marien\u2010Hospital  Hagen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Haenel","sequence":"additional","affiliation":[{"name":"Hematology, Oncology and Stem Cell Transplantation Klinikum Chemnitz GmbH  Chemnitz Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Nogai","sequence":"additional","affiliation":[{"name":"Internal Medicine III Charit\u00e9 Campus Benjamin Franklin  Berlin Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christof","family":"Scheid","sequence":"additional","affiliation":[{"name":"Internal Medicine University of Cologne  Cologne Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Salwender","sequence":"additional","affiliation":[{"name":"Hematology, Oncology and Palliative Care Asklepios Klinik Altona  Hamburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Fenk","sequence":"additional","affiliation":[{"name":"Hematology, Oncology and Clinical Immunology University of Duesseldorf  Duesseldorf Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ullrich","family":"Graeven","sequence":"additional","affiliation":[{"name":"Hematology, Oncology and Gastroenterology Maria\u2010Hilf\u2010Krankenhaus  M\u00f6nchengladbach Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Reimer","sequence":"additional","affiliation":[{"name":"Hematology, Oncology and Stem Cell Transplantation Evangelisches Krankenhaus Essen\u2010Werden gGmbH  Essen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Schmidt\u2010Hieber","sequence":"additional","affiliation":[{"name":"Hematology and Oncology Helios\u2010Hospital Berlin Buch  Berlin Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Goerner","sequence":"additional","affiliation":[{"name":"Hematology, Oncology and Palliative Care Community Hospital Bielefeld  Bielefeld Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo G. H.","family":"Schmidt\u2010Wolf","sequence":"additional","affiliation":[{"name":"Center for Integrated Oncology Med. Klinik III University Hospital Bonn  Bonn Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Klein","sequence":"additional","affiliation":[{"name":"Hematology and Oncology University Hospital Mannheim  Mannheim Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony D.","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Medicine V University Hospital Heidelberg  Heidelberg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut","family":"Goldschmidt","sequence":"additional","affiliation":[{"name":"Department of Medicine V University Hospital Heidelberg  Heidelberg Germany"},{"name":"National Center for Tumor Diseases Heidelberg University Hospital  Heidelberg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Wuchter","sequence":"additional","affiliation":[{"name":"Department of Medicine V University Hospital Heidelberg  Heidelberg Germany"},{"name":"Institute of Transfusion Medicine and Immunology Medical Faculty Mannheim Heidelberg University German Red Cross Blood Service Baden\u2010W\u00fcrttemberg \u2010 Hessen Mannheim Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,5,24]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-297325"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.099358"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70245-1"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.01.008"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.11.012"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2014.39"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.127"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-08-174946"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2014.196"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21323"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2014.33"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03206.x"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2011.133"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21206"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.54"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.578312"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701828"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.11.028"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.3109\/14653249.2012.681042"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2321-2"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12813"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.01.016"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.2783095.x"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404801"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2405035"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2405100"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.214"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/14653240701452800"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21360"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2013.52"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700867"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702879"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703840"},{"key":"e_1_2_7_35_1","first-page":"691","article-title":"Mobilization of peripheral blood progenitor cells with high\u2010dose cyclophosphamide (4 or 7\u00a0g\/m2) and granulocyte colony\u2010stimulating factor in patients with multiple myeloma","volume":"17","author":"Goldschmidt H","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1159\/000070967"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702514"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.04.008"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.02.011"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.118"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2013.175"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2011.01605.x"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.135"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2008.09.012"},{"key":"e_1_2_7_45_1","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1182\/blood.V112.11.3470.3470","article-title":"Successful harvesting of peripheral hematopoietic stem cells after induction treatment with bortezomib, adriamycin, dexamethasone (PAD) in patients with newly diagnosed multiple myeloma (MM)","volume":"112","author":"Goldschmidt H","year":"2008","journal-title":"Blood"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fejh.12888","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.12888","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T08:45:09Z","timestamp":1696322709000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.12888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,24]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1111\/ejh.12888"],"URL":"https:\/\/doi.org\/10.1111\/ejh.12888","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"type":"print","value":"0902-4441"},{"type":"electronic","value":"1600-0609"}],"subject":[],"published":{"date-parts":[[2017,5,24]]}}}